Cost increase per se is not necessarily a bad thing - for example if it leads to a more effective, but also more expensive, treatment.
The real question is how much of that cost increase is due to treatment effectiveness increase, and how much is due to economic inefficiency (e.g. transaction cost increase due to the multiple payer system, information asymmetry, or preference of treatment over prevention).
wojtek